那他珠单抗在多发性硬化症患者中的应用。 - Suppr

Suppr

超能文献

Use of natalizumab in multiple sclerosis patients.

作者信息

O'Connor Paul W

机构信息

Department of Neurology, St. Michael's Hospital, Toronto, ON, Canada.

出版信息

Can J Neurol Sci. 2010 Jan;37(1):98-104. doi: 10.1017/s0317167100009720.

DOI:10.1017/s0317167100009720

PMID:20169781

Abstract

摘要

相似文献

Use of natalizumab in multiple sclerosis patients.

Can J Neurol Sci. 2010 Jan;37(1):98-104. doi: 10.1017/s0317167100009720.

[Biological treatment of multiple sclerosis].

Ugeskr Laeger. 2008 Jun 9;170(24):2156-9.

[Development of new therapies for multiple sclerosis].

Tidsskr Nor Laegeforen. 2011 May 6;131(8):832-6. doi: 10.4045/tidsskr.10.0077.

Natalizumab treatment for multiple sclerosis.

Arq Neuropsiquiatr. 2014 Dec;72(12):911-2. doi: 10.1590/0004-282X20140198.

[Current treatment of multiple sclerosis].

Rev Med Interne. 2010 Aug;31(8):575-80. doi: 10.1016/j.revmed.2009.08.008. Epub 2010 Jun 25.

[Natalizumab].

Rev Infirm. 2008 Jul-Aug(142):49-51.

We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?

Expert Rev Neurother. 2014 Feb;14(2):127-30. doi: 10.1586/14737175.2014.874947. Epub 2014 Jan 13.

Discrepant findings in immune responses to JC virus in patients receiving natalizumab.

Lancet Neurol. 2010 Jun;9(6):565-6; author reply 566-7. doi: 10.1016/S1474-4422(10)70124-1.

[Natalizumab in multiple sclerosis: the second treatment revolution].

Presse Med. 2008 Jan;37(1 Pt 2):81-4. doi: 10.1016/j.lpm.2007.10.004. Epub 2007 Nov 26.

Washout period for immune-modifying drugs before natalizumab therapy.

Am J Health Syst Pharm. 2008 Jan 1;65(1):18-9. doi: 10.2146/ajhp070334.

引用本文的文献

Effects of low dose methotrexate on relapsing-remitting multiple sclerosis in comparison to Interferon β-1α: A randomized controlled trial.

J Res Med Sci. 2011 Apr;16(4):457-62.

Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants.

Antioxid Redox Signal. 2011 Sep 15;15(6):1607-38. doi: 10.1089/ars.2010.3522. Epub 2011 May 11.

Isoforms of vitamin E differentially regulate inflammation.

Endocr Metab Immune Disord Drug Targets. 2010 Dec;10(4):348-66. doi: 10.2174/1871530311006040348.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Use of natalizumab in multiple sclerosis patients.

Can J Neurol Sci. 2010 Jan;37(1):98-104. doi: 10.1017/s0317167100009720.

[Biological treatment of multiple sclerosis].

Ugeskr Laeger. 2008 Jun 9;170(24):2156-9.

[Development of new therapies for multiple sclerosis].

Tidsskr Nor Laegeforen. 2011 May 6;131(8):832-6. doi: 10.4045/tidsskr.10.0077.

Natalizumab treatment for multiple sclerosis.

Arq Neuropsiquiatr. 2014 Dec;72(12):911-2. doi: 10.1590/0004-282X20140198.

[Current treatment of multiple sclerosis].

Rev Med Interne. 2010 Aug;31(8):575-80. doi: 10.1016/j.revmed.2009.08.008. Epub 2010 Jun 25.

[Natalizumab].

Rev Infirm. 2008 Jul-Aug(142):49-51.

We know how to prescribe natalizumab for multiple sclerosis, but do we know how to withdraw it?

Expert Rev Neurother. 2014 Feb;14(2):127-30. doi: 10.1586/14737175.2014.874947. Epub 2014 Jan 13.

Discrepant findings in immune responses to JC virus in patients receiving natalizumab.

Lancet Neurol. 2010 Jun;9(6):565-6; author reply 566-7. doi: 10.1016/S1474-4422(10)70124-1.

[Natalizumab in multiple sclerosis: the second treatment revolution].

Presse Med. 2008 Jan;37(1 Pt 2):81-4. doi: 10.1016/j.lpm.2007.10.004. Epub 2007 Nov 26.

Washout period for immune-modifying drugs before natalizumab therapy.

Am J Health Syst Pharm. 2008 Jan 1;65(1):18-9. doi: 10.2146/ajhp070334.

引用本文的文献

Effects of low dose methotrexate on relapsing-remitting multiple sclerosis in comparison to Interferon β-1α: A randomized controlled trial.

J Res Med Sci. 2011 Apr;16(4):457-62.

Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants.

Antioxid Redox Signal. 2011 Sep 15;15(6):1607-38. doi: 10.1089/ars.2010.3522. Epub 2011 May 11.

Isoforms of vitamin E differentially regulate inflammation.

Endocr Metab Immune Disord Drug Targets. 2010 Dec;10(4):348-66. doi: 10.2174/1871530311006040348.